HOME >> MEDICINE >> NEWS
Elan and Biogen Idec announce results from Phase III maintenance trial of Antegren

Concomitant use of corticosteroids were reduced or eliminated in the study

NEW ORLEANS, MAY 18, 2004 Elan Corporation, plc and Biogen Idec announced that in a Phase III maintenance study, ANTEGREN (natalizumab) maintained clinical response and remission rates throughout six months among patients with Crohn's disease (CD) who had previously achieved clinical response. Additionally, a majority of natalizumab-treated patients who were also on chronic corticosteroid therapy were able to withdraw from corticosteroids and maintain response in contrast to those patients on placebo. The findings of ENACT-2 (Evaluation of Natalizumab As Continuous Therapy) will be presented for the first time at the Digestive Disease Week (DDW) annual meeting in New Orleans.

Crohn's disease, a chronic, progressive immune-mediated disease of the gastrointestinal tract, can cause a range of debilitating symptoms such as severe diarrhea, cramping or abdominal pain and malnutrition. Current treatment options for the disease are limited.

"The results of ENACT-2 suggest the potential of natalizumab as a maintenance therapy for patients with Crohn's disease," said William J. Sandborn, MD, professor of medicine at the Mayo Medical School. "This study demonstrated sustained clinical response and remission rates throughout six months on natalizumab. It also showed that natalizumab may help patients eliminate or reduce concomitant use of corticosteroids from their chronic treatment regimen. These results and the other clinical data presented at DDW are very exciting, and support the continued development of natalizumab as both an induction and maintenance treatment."

ENACT-2 STUDY FINDINGS
ENACT-2 assessed 339 natalizumab-responders from the induction study ENACT-1 (a 3-month study in patients with active CD) for the effect of natalizumab as a maintenance therapy. In the international, multi-center, double-blind, placebo-controlled tria
'"/>

Contact: Amy Losak
amy.losak@ketchum.com
646-935-3917
Ketchum
18-May-2004


Page: 1 2 3

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
4. IADR & GSK announce 2005 Innovation in Oral Care Awards
5. Innovation prize finalists announced in Science of Better
6. ASGE announces grant recipients in annual research awards program
7. The American Academy of Nurse Practitioners and Blackwell Publishing announce partnership
8. Novartis announces collaboration with Bayer for EMSELEX
9. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
10. Voluntary health organizations, publishers announce major information initiative
11. Mayo Clinic researchers announce promising next generation treatments for multiple myeloma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2018)... (PRWEB) , ... September 01, ... ... Mammography is proud to add HydraFacial MD® Elite to its leading menu ... uses patented, vortex-suction technology and an infusion of clinically-proven ingredients to dramatically ...
(Date:9/1/2018)... ... August 31, 2018 , ... SignatureCare Emergency Center is ... for the Fall semester to a deserving student. Get your applications in now as ... was awarded to Hanna Wu who is a medical student at Texas Southern University. ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... | 2018" list. , This list includes independent community hospitals as well as ... others care for small communities outside of large cities. The hospitals continue to ...
(Date:8/31/2018)... ... 31, 2018 , ... The social impact documentary feature film on homelessness, OFF ... NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has been faring well at film ... Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, and Top Indie Film ...
(Date:8/31/2018)... ... August 31, 2018 , ... Rudina Thanasi, a scientifically validated ... energy treated nutraceutical to improve overall immunity and to combat inflammatory and autoimmune ... well as, inflammation. The following data was reported:,     Over ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... Calif. (PRWEB) , ... September ... ... phage display for molecular evolution incorporate deep sequencing to enable greater library ... construction and biophysical follow-up of potential hits remain. , Multiplexed phage display ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... The ultimate ... Located at 31-57 31st St., the new arrival is called Form50 Fitness . ... by Sebastien Lagree called The Megaformer™ - a hybrid Pilates reformer with pulleys, weights, ...
(Date:9/13/2018)... ... September 13, 2018 , ... NCPDP announced today that its ... correct implementation of the NCPDP SCRIPT Standard Version 2017071 ahead of the January ... identified by the industry as vital enhancements in improving patient safety, clinical decision-making, ...
Breaking Medicine Technology:
Cached News: